Fine-needle aspiration biopsy and Bethesda classification in the diagnostics of the tumours of the thyroid gland – a retrospective study
Authors:
V. Kubec 1; M. Riant 1; P. Škopek 1; P. Hrabačka 1; M. Horáková 2,3
Authors‘ workplace:
Bioptická laboratoř s. r. o., Plzeň
2; Šiklův ústav patologie LF UK a FN Plzeň
3
Published in:
Otorinolaryngol Foniatr, 73, 2024, No. 1, pp. 16-21.
Category:
Original Article
doi:
https://doi.org/10.48095/ccorl202416
Overview
Introduction: Thyroid nodule is a pathology with a prevalence of 19–68% of the population, with a thyroid gland carcinoma proven in 7–15% of these cases. Bethesda classification is a standardized system for cytology findings evaluation. Aim of work: The aim of our work was to compare a predicted preoperative diagnosis including Bethesda classification and the final histology results, to define malignancy risk for Bethesda categories and to compare our findigs with foreign papers. Material and methods: A retrospective, observational study. In a group of 330 patients with performed operation on the thyroid gland (total thyroidectomy or hemithyroidectomy) at the ENT department of the University hospital in Pilsen between 2016 and 2017 there was a group of 180 patients (147 female and 33 male patients) with preoperatively known Bethesda category. We have compared an expected diagnosis and postoperatively known histology diagnosis, determined a risk of malignancy rate for each category of Bethesda classification and compared our results with a foreign literature. Results: In the group of our patients, we have determined a risk of malignancy rate for Bethesda I. category as 14.29%, same as for Bethesda II. For Bethesda III. as 15.79%, Bethesda IV. as 10.64%, Bethesda V. as 52.17% and Bethesda VI. category as 100%. Conclusion: Fine- -needle aspiration biopsy of thyroid gland nodules is a basic diagnostic method, which facilitates categorization and stratification of a risk of malignancy in cytological findings. In our group of patients, a risk of malignancy rate differs in Bethesda I. and II. category, our risk of malignancy rate is higher compared to foreign literature, which, we believe, is a statistical error due to a rather small set of patients.
Keywords:
thyroid nodule – Bethesda classification – fine-needle aspiration biopsy – risk of malignancy rate
Sources
1. Fryšák Z, Karásek D, Halenka M. Pacient s chorobou štítné žlázy. Interní Med 2012; 14 (5): 213–216.
2. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126 (3): 226–231. Doi: 10.7326/0003-4819-126-3-199702010-00009.
3. Guth S, Theune U, Aberle J et al. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39 (8): 699–706. Doi: 10.1111/j.1365-2362.2009.02162.X.
4. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351 (17): 1764–1771. Doi: 10.1056/NEJMcp031436.
5. Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA 2004; 292 (21): 2632–4262. Doi: 10.1001/jama.292.21.2632.
6. Ho AS, Sarti EE, Jain KS et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014; 24 (5): 832–839. Doi: 10.1089/thy.2013.0317.
7. Astl J. Chirurgická léčba nemocí štítné žlázy. Praha: Jessenius Maxdorf 2007: 70–71.
8. Cibas ES, Ali SZ. The 2017 Bethesda system for Reporting Thyroid Cytopathology. Thyroid 2017; 27 (11): 1341–1346. Doi: 10.1089/thy.2017.0500.
9. Baloch Z, LiVolsi VA. The Bethesda system for reporting thyroid cytology (TBSRTC): From look-backs to look-ahead. Diagn Cytopathol 2020; 48 (10): 862–866. Doi: 10.1002/dc.24385.
10. Dušková J. Aktuální otázky tenkojehlové aspirační biopsie štítné žlázy. Čes-slov Patol 2019; 55 (1): 13–23.
11. Haugen BR, Alexander EK, Bible KC et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force On Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (1): 1–133. Doi: 10.1089/thy.2015.0020.
12. Jiskra J. Diagnostika a další péče o pacienty s tyreoidálními uzly: Doporučení American thyroid association 2015 modifikované pro podmínky České republiky. Čas lék čes 2017; 156 (5): 241–251.
13. Leenhardt L, Erdogan MF, Hegedus L et al. European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid 2013; 2 (3): 147–159. Doi: 10.1159/000354537.
14. Srbová L, Gabalec F, Ryška A et al. Results of retrospective classification of thyroid FNAs according to the Bethesda system: Would this have improved accuracy? Cytopathology 2015; 26 (4): 231–237. Doi: 10.1111/cyt.12171.
15. Kwon H, Kim WG, Eszlinger M et al. Molecular diagnosis using residual liquid-based cytology materials for patients with nondiagnostic or indeterminate thyroid nodules. Endocrinol Metab (Seoul) 2016; 31 (4): 586–591. Doi: 10.3803/EnM.2016.31.4.586.
16. Tripathy K, Misra A, Ghosh JK. Efficacy of liquid-based cytology versus conventional smears in FNA samples. J Cytol 2015; 32 (1): 17–20. Doi: 10.4103/0970-9371.155255.
17. Singh RS, Wang HH. Eliminating the ‘atypia of undetermined significance/follicular lesion of undetermined significance‘ category from the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2011; 136: 896–902. Doi: 10.1309/AJCPIX52MBOKTICP.
18. VanderLaan PA, Marquesee E, Krane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 2011; 136 (4): 572–577. Doi: 10.1309/AJCPO0BQ2YSKPXXP.
19. Ludvíková M, Kholová I. Přehled dosavadních zkušeností s mezinárodní klasifikací tenkojehlové aspirační cytologie štítné žlázy Bethesda 2010. Cesk Patol 2014; 50 (3): 155–160.
20. Čáp J, Ryška A. Aspirační cytologie štítné žlázy. Vnitr Lek 2007; 53 (7–8): 799–803.
21. Fonseca E, Sobrinho-Simoes M. Diagnostic problems in differentiated carcinomas of the thyroid. Pathol Res Pract 1995; 191 (4): 318–331. Doi: 10.1016/S0344-0338 (11) 80885-X.
22. Uhliarová B, Bugová G, Szépe P et al. Aspiračná cytológia versus peroperačná histológia v diagnostike uzlov štítnej žľazy. Otorinolaryngol Foniatr 2016; 65 (2): 82–87.
23. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009; 19 (11): 1159–1165. Doi: 10.1089/thy.2009.0274.
24. Godoi Cavalheiro B, Kober Nogueira Leite A, Luongo de Matos L et al. Malignancy rates in thyroid nodules classified as Bethesda categories III and IV: Retrospective data from a tertiary center. Int J Endocrinol Metab 2017; 16 (1): e12871. Doi: 10.5812/ijem.12871.
Přijato k recenzi: 6. 10. 2022
Přijato k tisku: 15. 12. 2022
MUDr. Vojtěch Kubec
Otorhinolaryngologická klinika
LF UK a FN Plzeň
Edvarda Beneše 1128/13
305 99 Plzeň-Bory
kubecv@fnplzen.cz
Labels
Audiology Paediatric ENT ENT (Otorhinolaryngology)Article was published in
Otorhinolaryngology and Phoniatrics
2024 Issue 1
Most read in this issue
- PFAPA syndrome in children, our experience with surgical treatment – review article with a case report
- Fine-needle aspiration biopsy and Bethesda classification in the diagnostics of the tumours of the thyroid gland – a retrospective study
- Nontuberculous mycobacterial infections in children
- Haemangioma of the temporal muscle – a case report